Chair of FDA's vac­cine ad­comm — who's al­so a lead in­ves­ti­ga­tor of Mod­er­na's vac­cine — re­cus­es her­self from Covid-19 talks

When the FDA’s Vac­cines and Re­lat­ed Bi­o­log­i­cal Prod­ucts Ad­vi­so­ry Com­mit­tee meets next month to dis­cuss the de­vel­op­ment and au­tho­riza­tion of Covid-19 vac­cines, the chair­woman won’t be there.

Hana El Sahly has re­cused her­self from the ex­pert pan­el’s re­view of the top­ic, cit­ing her role as a lead in­ves­ti­ga­tor in Mod­er­na’s Phase III tri­al, Reuters re­port­ed. An as­so­ciate pro­fes­sor of vi­rol­o­gy and mi­cro­bi­ol­o­gy at Bay­lor Col­lege of Med­i­cine in Hous­ton, El Sahly was ap­point­ed the chair­woman last year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.